Literature DB >> 34298040

FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.

Pengfei Zhang1, Yuan Shao1, Fang Quan1, Lifeng Liu1, Jin Yang2.   

Abstract

AIMS: The high glycolysis state of tumor cells is closely related to radioresistance. Fructose-1,6-bisphosphatase (FBP1) can regulate aerobic glycolysis and exerts tumor suppressor effects in many cancers, but its role in nasopharyngeal carcinoma (NPC) remains to be investigated.
MATERIALS AND METHODS: RT-qPCR was used to measure FBP1 mRNA level. Glucose consumption, lactic acid production and ATP level was determined to evaluate glycolysis. The sensitivity of NPC cells to radiation was analyzed by MTT assay. Apoptosis was performed using flow cytometry. Gain- and loss-of function assays were carried out to explore the specific role of FBP1 and FBXW7 (F-box and WD repeat domain-containing 7) in NPC cell functions. The interactions between FBXW7 and FBP1 or mTOR were validated with co-immunoprecipitation assay. The in vivo experiments with xenografts were used to evaluate the role of FBP1 in tumor growth. KEY
FINDINGS: FBP1 expression was lower in NPC tissues and cells than in normal controls and nasopharyngeal epithelial cells. Human recombinant FBP1 (rh-FBP1) treatment suppressed glycolysis in NPC cells. Besides, silencing FBP1 weakened the radiosensitivity and alleviated radiation-induced apoptosis and DNA damage by promoting glycolysis. Mechanism exploration found that FBP1 promoted FBXW7 protein level through suppressing the autoubiquitination of FBXW7. Then, FBXW7 restrained mTOR level by facilitating mTOR ubiquitination, thereby suppressing glycolysis and promoting radiation-induced apoptosis and DNA damage. Furthermore, overexpressing FBP1 in vivo hindered tumor growth and enhanced the antitumor activity of radiation. SIGNIFICANCE: FBP1 promoted the radiosensitivity in NPC cells by inhibiting glycolysis through the FBXW7/mTOR axis.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FBP1; FBXW7/mTOR axis; Glycolysis; Nasopharyngeal carcinoma; Radiosensitivity

Year:  2021        PMID: 34298040     DOI: 10.1016/j.lfs.2021.119840

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.

Authors:  Liangliang Xing; Leidi Xu; Yong Zhang; Yinggang Che; Min Wang; Yongxiang Shao; Dan Qiu; Honglian Yu; Feng Zhao; Jian Zhang
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 2.  FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies.

Authors:  Wenyue Shen; Quanwei Zhou; Chenxi Peng; Jiaheng Li; Qizhi Yuan; Hecheng Zhu; Ming Zhao; Xingjun Jiang; Weidong Liu; Caiping Ren
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

3.  Exosomal miR-106a-5p accelerates the progression of nasopharyngeal carcinoma through FBXW7-mediated TRIM24 degradation.

Authors:  Chang-Wu Li; Jing Zheng; Guo-Qing Deng; Yu-Guang Zhang; Yue Du; Hong-Yan Jiang
Journal:  Cancer Sci       Date:  2022-03-29       Impact factor: 6.518

4.  Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma.

Authors:  Alexander Damanakis; Patrick Sven Plum; Florian Gebauer; Wolfgang Schröder; Reinhard Büttner; Thomas Zander; Christiane Josephine Bruns; Alexander Quaas
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-27       Impact factor: 4.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.